Disulfiram

IF YOU ARE A BRANCH OF BOOTS, LLOYDS, ROWLANDS, WELL, WILLIS, MORRISONS, GILBRIDE’S & INVERCOAST YOU ARE NOT REQUIRED TO SIGN THE SLA AS THESE COMPANIES OPERATE A SINGLE SIGN UP PROCESS WHICH IS MANAGED VIA A CENTRAL POINT.

For those pharmacies registered to provide the supervised disulfiram service:

Historically within GG&C, pharmacies have been paid per supervision of disulfiram, which made claiming complicated and cumbersome. On 1^st July 2020, the Pharmacy Contractors Committee agreed to a £15 single monthly payment for disulfiram patients. A patient needs to attend once or more for disulfiram supervision in a calendar month or have instalment dispensing specified on their prescription without supervision. Communicating any concerns, for example a missed dose/collection, promptly (within 24 hours) remains the most important part of the service. An interim claim form was employed (July to October 2020) while a NEO module was under development. The NEO module will now go live on 1^st November 2020.

From 1^st November, the new NEO alcohol module should be used for:

Recording/reporting a missed dose of disulfiram (within 24 hours), the system will send an automated email to the team for you. No further doses should be supplied/supervised until the team has advised to do so.
Monthly paper free disulfiram claims (first claim in December 2020 for service provided in November 2020).

Breathalysing although usually a standard part of the service, as previously communicated due to COVID-19 infection risk, breathalysing should not be part of the assessment until further notice.

Please email ADRS.PharmacyTeam@ggc.scot.nhs.uk with any queries.

Responsible Person: Jennifer Torrens
Last Updated: 19/07/2024